References
- 1. E. De Clercq, Antiviral drugs in current clinical use, J. Clin. Virol. 30 (2004) 115–133; DOI: 10.1016/j.jcv.2004.02.009.10.1016/j.jcv.2004.02.009
- 2. P. J. O’Dwyer, S. A. King, J. Plowman, C. K. Grieshaber, D. F. Hoth and B. Leyland-Jones, Pyrazole: preclinical reassessment, Invest. New Drug6 (1988) 305–310.
- 3. A. Bekhit and T. Abdel-Aziem, Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents, Bioorg. Med. Chem. 12 (2004) 1935–1945; DOI: 10.1016/j.bmc.2004.01.037.10.1016/j.bmc.2004.01.037
- 4. K. L. Kees, J. J. Fitzgerald, K. E. Steiner, J. F. Mattes, B. Mihan and T. Tosi, New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones, J. Med. Chem. 39 (1996) 3920–3928.
- 5. A. Geronikaki, E. Babaev, J. Dearden, W. Dehaen, D. Filimonov, I. Galaeva, V. Krajneva, A. Lagunin, F. macaev, G. Molodavkin, V. Poroikov, S. Pogrebnoi, V. Saloutin, A. Stepanchikova, E. Stingaci, N. Tkach, L. Vlad and T. Voroninaf, Design, synthesis, computational and biological evaluation of new anxyiolytics, Bioorg. Med. Chem.12 (2004) 6559–6568; DOI: 10.1016/j.bmc.2004.09.016.10.1016/j.bmc.2004.09.016
- 6. D. Sil, R. Kumar, A. Sharon, P. R. Malik and V. Ram, Stereoselective alkenylation of a 1,3-disubstituted pyrazol-5-one through ring transformation of 2H-pyran-2-ones, Tetrahedron Lett.46 (2005) 3807–3809; DOI: 10.1016/j.tetlet.2005.03.207.10.1016/j.tetlet.2005.03.207
- 7. J. S. Larsen, M. A. Zahran, E. B. Pedersen and C. Nielsen, Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1, Monatsh. Chem. 130 (1999) 1167–1173.
- 8. A. Arrieta, J. R. Carrillo, F. P. Cossl, E. Ortiz, M. J. Gomez-Escalonilla, A. de la Hoz, F. Langa and A. Moreno, Efficient tautomerization hydrazone-azomethine imine under microwave irradiation. Synthesis of [4,3′] and [5,3′]bipyrazoles, Tetrahedron54 (1998) 13167–13180; DOI: 10.1016/S0040-4020(98)00798-4.10.1016/S0040-4020(98)00798-4
- 9. G. M. Nitulescu, C. Draghici and O. T. Olaru, New potential antitumor pyrazole derivatives: Synthesis and cytotoxic evaluation, Int. J. Mol. Sci.14 (2013) 21805–21818; DOI: 10.3390/ijms141121805.10.3390/ijms141121805385603624192822
- 10. J. L. Wang, D. Liu, Z. J. Zhang, S. Shan, X. Han, S. M. Srinivasula, C. M. Croce, E. S. Alnemri and Z. Huang, Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells, Proc. Natl. Acad. Sci. USA97 (2000) 7124–7129.10.1073/pnas.97.13.71241651010860979
- 11. E. S. El-Tamany, F. A. El-Shahed and B. H. Mohamed, Synthesis and biological activity of some pyrazole derivatives, J. Serb. Chem. Soc.64 (1999) 9–18.
- 12. M. E. A. Zaki, H. S. Soliman, O. A. Hiekal and A. E. Rashad, Pyrazolopyranopyrimidines as a class of anti-inflammatory agents, Z. Naturforsch. C. 61 (2006) 1–5.10.1515/znc-2006-1-20116610208
- 13. F. M. Abdelrazek, P. Metz, N. H. Metwally and S. F. El-Mahrouky, Synthesis and molluscicidal activity of new cinnoline and pyrano[2,3-c]pyrazole derivatives, Arch. Pharm. 339 (2006) 456–460.10.1002/ardp.20060005716795107
- 14. F. M. Abdelrazek, P. Metz, O. Kataeva, A. Jager and S. F. EI-Mahrouky, Synthesis and molluscicidal activity of new chromene and pyrano[2,3-c]pyrazole derivatives, Arch. Pharm.340 (2007) 543–548.10.1002/ardp.20070015717912679
- 15. N. Foloppe, L. M. Fisher, R. Howes, A. Potter, A. G. S. Robertson and A. E. Surgenor. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening, Bioorg. Med. Chem.14 (2006) 4792–4802; DOI: 10.1016/j.bmc.2006.03.021.10.1016/j.bmc.2006.03.02116574416
- 16. S. A. El-Assiery, G. H. Sayed and A. Fouda, Synthesis of some new annulated pyrazolo-pyrido (or pyrano) pyrimidine, pyrazolopyridine and pyranopyrazole derivatives, Acta Pharm.54 (2004) 143–150.
- 17. C. M. Ashraf, S. S. Ali and A. Hussain, Organic reaction in aqueous solution, Part-VIII: Effect of Sonication on the reaction of thiosemicarbazide with ethyl acetoacetate, J. Chem. Soc. Pak.20 (1998) 145–149.
- 18. M. M. H. Bhuiyan, M. I. Hossain, M. A. Alam and M. M. Mahmud, Microwave assisted Knoevenagel condensation: synthesis and antimicrobial activites of some arylidene-malononitriles, Chem. J.2 (2012) 31–37.
- 19. S. R. Jain and A. Kar, The antibacterial activity of some essential oils and their combinations. Planta Med.20 (1971) 118–123; DOI: 10.1055/s-0028-1099675.10.1055/s-0028-10996755119010
- 20. H. Ericsson and J. C. Sherris, Antibiotic sensitivity testing. Report of an international collaborative study, Acta Pathol. Microbiol. Scand. Sect. B217 (1971) 1–90.
- 21. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer drug screening, J. Natl. Cancer Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.10.1093/jnci/82.13.11072359136
- 22. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and J. M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst. 83 (1991) 757–776; DOI: 10.1093/jnci/83.11.757.10.1093/jnci/83.11.7572041050
- 23. A. B. A. El-Gazzar, H. N. Hafez and G. A. M. Nawwar, New acyclic nucleoside analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines, Eur. J. Med. Chem.44 (2009) 1427–1436; DOI: 10.1016/j.-ejmech.2008.09.030.